Post-approval commitment for EMA-2023-0002. Category: Manufacturing. Priority: high.

Commitment ID
COM-102
Application
Authority
European Medicines Agency
Category
Manufacturing
Priority
high
Status
In Progress
Due Date
2025-07-26
Completed At
—
Owner
Marcus Webb
Created
2023-06-19
Description

Provide confirmatory bioequivalence study for 200 mg strength

Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.